Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#874
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$61.79
Modal Pasaran
$27.51B
Perubahan (1 hari)
2.52%
Perubahan (1 tahun)
68.69%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Nisbah P/S bagi Royalty Pharma plc (RPRX)
Nisbah P/S pada October 2026 TTM: 10.31
Menurut laporan kewangan dan harga saham terkini Royalty Pharma plc, nisbah P/S semasa (TTM) ialah 10.31. Pada akhir 2023, nisbah P/S syarikat ialah 5.34.
Sejarah nisbah P/S untuk Royalty Pharma plc dari 2015 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 10.31 | 104.99% |
| 2024 | 5.03 | -5.87% |
| 2023 | 5.34 | -30.98% |
| 2022 | 7.74 | 7.16% |
| 2021 | 7.22 | -21.12% |
| 2020 | 9.15 | 5.36% |
| 2019 | 8.69 | -1.07% |
| 2018 | 8.78 | -10.97% |
| 2017 | 9.86 | -31.45% |
| 2016 | 14.39 | -11.98% |
| 2015 | 16.35 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 15.12 | 46.67% |
US
|
|
| 2.36 | -77.11% |
HK
|
